EcoDrugPlus

26s Proteasome Non-Atpase Regulatory Subunit 6-Like

Ensembl ID : ENSNBRG00000020732
Gene Symbol: LOC102796322
3 Cross references
212 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 7-Like

Ensembl ID : ENSNBRG00000001963
Gene Symbol: LOC102795546
3 Cross references
235 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 8-Like

Ensembl ID : ENSNBRG00000003976
Gene Symbol: LOC102787089
3 Cross references
211 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase

Ensembl ID : ENSNBRG00000008965
Gene Symbol: HMGCR
1 Cross references
195 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase-Like

Ensembl ID : ENSNBRG00000020016
Gene Symbol: LOC102791185
3 Cross references
205 Possible Orthologues:

3-Oxo-5-Alpha-Steroid 4-Dehydrogenase 2-Like

Ensembl ID : ENSNBRG00000012600
Gene Symbol: LOC102792730
3 Cross references
191 Possible Orthologues:

3-Phosphoinositide-Dependent Protein Kinase 1-Like

Ensembl ID : ENSNBRG00000022729
Gene Symbol: LOC102787391
3 Cross references
221 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase-Like

Ensembl ID : ENSNBRG00000016860
Gene Symbol: LOC102791370
3 Cross references
204 Possible Orthologues:

40s Ribosomal Protein S10-Like

Ensembl ID : ENSNBRG00000009084
Gene Symbol: LOC102793608
3 Cross references
379 Possible Orthologues:

40s Ribosomal Protein S11-Like

Ensembl ID : ENSNBRG00000016251
Gene Symbol: LOC102798944
3 Cross references
286 Possible Orthologues:

40s Ribosomal Protein S13-Like

Ensembl ID : ENSNBRG00000015738
Gene Symbol: LOC102780731
3 Cross references
377 Possible Orthologues:

40s Ribosomal Protein S14-Like

Ensembl ID : ENSNBRG00000018605
Gene Symbol: LOC102778289
3 Cross references
255 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).